Edwardsville, Illinois (MARCH 08, 2024) – Flint Cooper proudly announces that one of its esteemed attorneys, Trent Miracle, has been appointed to serve as Co-Lead Counsel in the Suboxone (Buprenorphine/Naloxone) Film Products Liability Litigation, MDL No. 3092. This prestigious appointment by the United States District Court for the Northern District of Ohio, Eastern Division, recognizes Miracle’s exceptional legal acumen and dedication to justice.
In this role, Miracle will be responsible for coordinating plaintiffs’ activities during pretrial proceedings, ensuring that the rights of those affected by the Suboxone products are protected, and advocating for their interests throughout the litigation process.
“We are incredibly proud of Trent’s appointment to this important leadership position,” said Flint Cooper Managing Partner, Ethan Flint. “His commitment to excellence and tireless advocacy make him an invaluable asset to our firm and to the clients we serve.”
Additionally, Flint Cooper extends heartfelt congratulations to the other attorneys appointed to key leadership positions in this litigation:
- Ashlie Case Sletvold of Peiffer Wolf Carr Kane Conway & Wise, LLP
- Erin K. Copeland of Fibich, Leebron, Copeland & Briggs
- Timothy J. Becker of Johnson // Becker, PLLC
Each of these individuals brings a wealth of experience and expertise to their respective roles, and we commend them for their dedication to advancing justice on behalf of the plaintiffs.
For media inquiries or further information, please contact Fred Licon at (618) 277-4888 or via email at fred@flintcooper.com
